Acquisitions

12 Months Ended

Dec. 31, 2025

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

During the years ended December 31, 2025, 2024 and 2023, the Company completed several acquisitions to strengthen its current market share in existing markets or to expand into new markets. Each of the Company’s acquisitions was accounted for using the acquisition method pursuant to the requirements of FASB ASC Topic 805, Business Combinations, and are included in the Company’s consolidated financial statements since the respective acquisition date. The goodwill generated from these acquisitions is attributable to expected growth and cost synergies and the expected contribution of each acquisition to the Company’s overall strategy. The goodwill recorded during the year ended December 31, 2025 is expected to be deductible for tax purposes.

Year ended December 31, 2025

During the year ended December 31, 2025, the Company acquired certain assets of four providers of home medical equipment, and 100% of the equity interests in one provider of home medical equipment, each of which were accounted for as a business combination under ASC 805. The total consideration paid at closing for these acquisitions during the year ended December 31, 2025 consisted of cash payments totaling $42.8 million, and a deferred payment of $0.3 million.

The Company allocated the consideration paid to the net assets acquired based on their estimated acquisition date fair values. Based upon management’s evaluation, the consideration paid for all acquisitions during the year ended December 31, 2025 was allocated as follows during the period (in thousands):


Cash	$	379
Accounts receivable	779
Inventory	1,155
Equipment and other fixed assets	8,436
Other Long Term Assets	38
ROU Asset	2,522
Goodwill	33,260
Accounts payable and accrued expenses	(625)
Operating lease liabilities	(2,522)
Deferred Tax Liabilities	(309)
Net assets acquired	$	43,113

Year ended December 31, 2024

During the year ended December 31, 2024, the Company acquired certain assets from a provider of HME. The consideration paid at closing for the acquisition during the year ended December 31, 2024 consisted of a cash payment of $9.5 million.

The Company allocated the consideration paid to the net assets acquired based on their estimated acquisition date fair values. Based upon management’s evaluation, the consideration paid for the acquisition during the year ended December 31, 2024 was allocated as follows during the period (in thousands):


Inventory	$	192
Equipment and other fixed assets	249
Goodwill	9,095
Net assets acquired	$	9,536

Year ended December 31, 2023

During the year ended December 31, 2023, the Company acquired 100% of the equity interests of two providers of HME and acquired certain assets from four providers of home medical equipment. The following table summarizes the consideration paid at closing for all acquisitions during the year ended December 31, 2023 (in thousands):


Cash	$	19,943
Deferred payments	137
Total	$	20,080

The Company allocated the consideration paid to the net assets acquired based on their acquisition date fair values. Based upon management’s evaluation, the consideration paid for all acquisitions during the year ended December 31, 2023 was allocated as follows during the period (in thousands):


Cash	$	256
Accounts receivable	1,264
Inventory	1,483
Prepaid and other current assets	10
Equipment and other fixed assets	9,011
Operating lease right-of-use assets	5,506
Finance lease right-of-use assets	200
Goodwill	9,616
Accounts payable and accrued expenses	(713)
Operating lease liabilities	(5,506)
Finance lease liabilities	(200)
Other current liabilities	(847)
Net assets acquired	$	20,080